Christopher Robinson/LinkedIn
Jun 7, 2026, 15:53
Christopher Robinson: New Trial Compares Mirtazapine and Ondansetron for Treatment of Hyperemesis Gravidarum
Christopher Robinson, Associate Professor Maternal Fetal Medicine at University of South Carolina, shared a post on LinkedIn:
“Mirtazapine or ondansetron for hyperemesis gravidarum: a randomized placebo-controlled trial – PUQE-24 score during the intervention”
Title: Mirtazapine or ondansetron for hyperemesis gravidarum: a randomized placebo-controlled trial
Authors: Anne Ostenfeld, Sif Emilie Carlsen, Andreas Kryger Jensen, Tina Bergmann Futtrup, Hanne Brix Westergaard, Lars Henning Pedersen, Jon Trærup Andersen, Tonny Studsgaard Petersen, Ellen Christine Leth Løkkegaard, VOMIT Investigation Group
Read more.
Stay updated on all scientific advances in the field of fertility with Fertility News.
Andreas Kryger Jensen
Anne Ostenfeld
Christopher Robinson
Ellen Christine Leth Løkkegaard
Fertility
Fertility News
Hanne Brix Westergaard
Hyperemesis Gravidarum
Jon Trærup Andersen
Lars Henning Pedersen
Mirtazapine
ondansetron
reproductive health
Reproductive Medicine
Sif Emilie Carlsen
Tina Bergmann Futtrup
Tonny Studsgaard Petersen
VOMIT Investigation Group
-
Jun 7, 2026, 15:54Barb Collura: 3 Key Takeaways From My May Travels
-
Jun 7, 2026, 15:44MFM Specialists and Genetic Counselors Collaborating to Support High-Risk Pregnancy Care – National Society of Genetic Counselors
-
Jun 7, 2026, 08:03Psychological Distress and Coping Strategies Among Women of Color Diagnosed with Infertility – Fertility and Sterility
-
Jun 7, 2026, 07:37FIGO Guidance on Contraceptive Strategies for Reducing Reproductive Cancer Risk – IJGO
-
Jun 7, 2026, 07:34Ubiquinol and Ubiquinone CoQ10 Two Forms Supporting Cellular Energy and Fertility Health – Fertility Plus
-
Jun 7, 2026, 07:28Marco Zaccaria: Modern Management of Müllerian Malformations Through Minimally Invasive Surgery
-
Jun 7, 2026, 07:25Emergency Caesarean Births in the UK Rising Trends Inequalities and the Urgent Need for Safer Maternity Care – RCOG
-
Jun 7, 2026, 07:22New Study Finds No Survival Advantage for Bilateral Oophorectomy in Cervical Adenocarcinoma – IJGC
-
Jun 7, 2026, 07:19Catherine Monk: Reimagining Perinatal and Infant Mental Health Through a Two-Generational Lens